- Previous Close
2.1200 - Open
2.0600 - Bid 2.0600 x --
- Ask 2.1200 x --
- Day's Range
1.9900 - 2.1200 - 52 Week Range
1.6850 - 2.9400 - Volume
3,236 - Avg. Volume
0 - Market Cap (intraday)
48.887M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.2000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Bioretec Oy, a medical device company, develops, manufactures, and markets bioresorbable orthopedic implants for the repair of bone and soft tissue injuries in children and adults worldwide. The company offers Activa IM-Nail, a bioabsorbable option for pediatric forearm intramedullary nailing; ActivaNail, an implant that is be used in upper or lower limbs to ensure successful bone regeneration; ActivaPin, a bioabsorbable implant for upper and lower limb fractures; and ActivaScrew, an absorbable surgical implant that is used in fracture treatment, osteotomy, arthrodesis, and bone graft surgery. It also provides ActivaScrew Cannulated that offers a range of fully threaded and partially threaded cannulated screws for fixation of fractures and osteotomies; ActivaScrew Interference, a tool for multiple uses regarding bone fractures, osteotomies, arthrodesesm, and bone grafts; ActivaScrew Interference TCP, a biocomposite interference screw; and RemeOs Screw, a magnesium screw implants. The company was formerly known as BCI Bioabsorbable Concepts Oy. Bioretec Ltd. was incorporated in 1998 and is headquartered in Tampere, Finland.
bioretec.comRecent News: 0TN.F
View MorePerformance Overview: 0TN.F
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is OMX Helsinki_PI (^OMXHPI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0TN.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0TN.F
View MoreValuation Measures
Market Cap
51.84M
Enterprise Value
47.28M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
12.84
Price/Book (mrq)
5.35
Enterprise Value/Revenue
10.41
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
-0.2000
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--